Page last updated: 2024-10-30

mefenamic acid and Child Development Disorders, Pervasive

mefenamic acid has been researched along with Child Development Disorders, Pervasive in 1 studies

Mefenamic Acid: A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of cyclooxygenase.
mefenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,3-dimethylphenyl group. Although classed as a non-steroidal anti-inflammatory drug, its anti-inflammatory properties are considered to be minor. It is used to relieve mild to moderate pain, including headaches, dental pain, osteoarthritis and rheumatoid arthritis.

Child Development Disorders, Pervasive: Severe distortions in the development of many basic psychological functions that are not normal for any stage in development. These distortions are manifested in sustained social impairment, speech abnormalities, and peculiar motor movements.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wittkowski, KM1
Sonakya, V1
Bigio, B1
Tonn, MK1
Shic, F1
Ascano, M1
Nasca, C1
Gold-Von Simson, G1

Other Studies

1 other study available for mefenamic acid and Child Development Disorders, Pervasive

ArticleYear
A novel computational biostatistics approach implies impaired dephosphorylation of growth factor receptors as associated with severity of autism.
    Translational psychiatry, 2014, Jan-28, Volume: 4

    Topics: Biostatistics; Calcium Channels; Child Development Disorders, Pervasive; Female; Genetic Predisposit

2014